{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T15:14:42Z","timestamp":1794928482213,"version":"4.9.1"},"reference-count":48,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2016,3,8]],"date-time":"2016-03-08T00:00:00Z","timestamp":1457395200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"Korea Health Technology R&D Project"},{"DOI":"10.13039\/501100003710","name":"Korea Health Industry Development Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003710","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Ministry of Health & Welfare, Republic of Korea","award":["HI15C1062"],"award-info":[{"award-number":["HI15C1062"]}]},{"name":"Bio & Medical Technology Development Program"},{"DOI":"10.13039\/100011512","name":"National Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011512","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004085","name":"MEST","doi-asserted-by":"publisher","award":["2012M3A9C6049783"],"award-info":[{"award-number":["2012M3A9C6049783"]}],"id":[{"id":"10.13039\/501100004085","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Basic Science Research Program"},{"name":"NRF of Korea"},{"DOI":"10.13039\/501100004085","name":"Ministry of Education Science and Technology","doi-asserted-by":"crossref","award":["2010-0003193"],"award-info":[{"award-number":["2010-0003193"]}],"id":[{"id":"10.13039\/501100004085","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>The green tea polyphenol epigallocatechin-3-gallate is a potent antioxidant. Here, we describe the effects of epigallocatechin-3-gallate on T cell differentiation and osteoclast differentiation in an animal model of arthritis. Mice with collagen-induced arthritis were injected intraperitoneally with epigallocatechin-3-gallate, 3 times\/wk after the primary immunization. Surface markers of T helper 17 cells and regulatory T cells were analyzed by flow cytometry. Flow cytometry, Western blotting, and enzyme-linked immunosorbent assays were used to evaluate the effect of epigallocatechin-3-gallate on cell signaling in the collagen-induced arthritis model. Epigallocatechin-3-gallate decreased the arthritis index and showed protective effects against joint destruction in collagen-induced arthritis mice. The expression of cytokines, oxidative stress proteins, and phosphorylated-signal transducer and activator of transcription-3, 705 and 727, were significantly less in mice treated with epigallocatechin-3-gallate than it was in controls. Epigallocatechin-3-gallate reduced the expression of osteoclast markers in vitro and in vivo relative to the control, and the antiosteoclastic activity was observed in epigallocatechin-3-gallate\u2013treated, interferon-\u03b3 knockout mice. The proportion of forkhead box protein 3\u2013positive regulatory T cells was increased in the spleens of mice treated with epigallocatechin-3-gallate compared with control mice, whereas the proportion of T helper 17 cells was reduced. In vitro, the expression of nuclear respiratory factor 2, heme oxygenase-1, and extracellular signal-regulated kinase was increased significantly by epigallocatechin-3-gallate. We demonstrated that the administration of epigallocatechin-3-gallate attenuated the symptoms of arthritis, inhibited osteoclastogenesis and T helper 17 cell activation, and increased the number of regulatory T cells. At the molecular level, the antiarthritic effects of epigallocatechin-3-gallate may be due to induction of phosphorylated\u2013extracellular signal-regulated kinase, nuclear respiratory factor 2, and heme oxygenase-1 and inhibition of signal transducer and activator of transcription-3 activation.<\/jats:p>","DOI":"10.1189\/jlb.3a0514-261rr","type":"journal-article","created":{"date-parts":[[2016,3,9]],"date-time":"2016-03-09T03:33:44Z","timestamp":1457494424000},"page":"559-568","source":"Crossref","is-referenced-by-count":60,"title":["Epigallocatechin-3-gallate ameliorates autoimmune arthritis by reciprocal regulation of T helper-17 regulatory T cells and inhibition of osteoclastogenesis by inhibiting STAT3 signaling"],"prefix":"10.1093","volume":"100","author":[{"given":"Seon-Yeong","family":"Lee","sequence":"first","affiliation":[{"name":"The Rheumatism Research Center, Catholic Research Institute of Medical Science, The Catholic University of Korea , Banpo-dong, Seocho-gu, Seoul , South Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Ok","family":"Jung","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Internal Medicine, Hallym University Kang-Nam Sacred Heart Hospital , Seoul , Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-Geol","family":"Ryu","sequence":"additional","affiliation":[{"name":"The Rheumatism Research Center, Catholic Research Institute of Medical Science, The Catholic University of Korea , Banpo-dong, Seocho-gu, Seoul , South Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hye-Jwa","family":"Oh","sequence":"additional","affiliation":[{"name":"The Rheumatism Research Center, Catholic Research Institute of Medical Science, The Catholic University of Korea , Banpo-dong, Seocho-gu, Seoul , South Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hye-Jin","family":"Son","sequence":"additional","affiliation":[{"name":"The Rheumatism Research Center, Catholic Research Institute of Medical Science, The Catholic University of Korea , Banpo-dong, Seocho-gu, Seoul , South Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung Hoon","family":"Lee","sequence":"additional","affiliation":[{"name":"The Rheumatism Research Center, Catholic Research Institute of Medical Science, The Catholic University of Korea , Banpo-dong, Seocho-gu, Seoul , South Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeong-Eun","family":"Kwon","sequence":"additional","affiliation":[{"name":"The Rheumatism Research Center, Catholic Research Institute of Medical Science, The Catholic University of Korea , Banpo-dong, Seocho-gu, Seoul , South Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun-Kyung","family":"Kim","sequence":"additional","affiliation":[{"name":"The Rheumatism Research Center, Catholic Research Institute of Medical Science, The Catholic University of Korea , Banpo-dong, Seocho-gu, Seoul , South Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mi-Kyung","family":"Park","sequence":"additional","affiliation":[{"name":"The Rheumatism Research Center, Catholic Research Institute of Medical Science, The Catholic University of Korea , Banpo-dong, Seocho-gu, Seoul , South Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung-Hwan","family":"Park","sequence":"additional","affiliation":[{"name":"The Rheumatism Research Center, Catholic Research Institute of Medical Science, The Catholic University of Korea , Banpo-dong, Seocho-gu, Seoul , South Korea"},{"name":"Center for Rheumatic Disease, Division of Rheumatology, Department of Internal Medicine, Seoul St. Mary\u2019s Hospital, The Catholic University of Korea , Banpo-dong, Seocho-gu, Seoul , South Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ho-Youn","family":"Kim","sequence":"additional","affiliation":[{"name":"The Rheumatism Research Center, Catholic Research Institute of Medical Science, The Catholic University of Korea , Banpo-dong, Seocho-gu, Seoul , South Korea"},{"name":"Center for Rheumatic Disease, Division of Rheumatology, Department of Internal Medicine, Seoul St. Mary\u2019s Hospital, The Catholic University of Korea , Banpo-dong, Seocho-gu, Seoul , South Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mi-La","family":"Cho","sequence":"additional","affiliation":[{"name":"The Rheumatism Research Center, Catholic Research Institute of Medical Science, The Catholic University of Korea , Banpo-dong, Seocho-gu, Seoul , South Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2016,3,8]]},"reference":[{"key":"2023011710414760100_B1","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/nature01661","article-title":"Evolving concepts of rheumatoid arthritis","volume":"423","author":"Firestein","year":"2003","journal-title":"Nature"},{"key":"2023011710414760100_B2","doi-asserted-by":"crossref","first-page":"R93","DOI":"10.1186\/ar2477","article-title":"TH-17 cells in rheumatoid arthritis","volume":"10","author":"Shahrara","year":"2008","journal-title":"Arthritis Res. Ther."},{"key":"2023011710414760100_B3","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/nri821","article-title":"CD4+ CD25+ suppressor T cells: more questions than answers","volume":"2","author":"Shevach","year":"2002","journal-title":"Nat. Rev. Immunol."},{"key":"2023011710414760100_B4","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1126\/science.1079490","article-title":"Control of regulatory T cell development by the transcription factor Foxp3","volume":"299","author":"Hori","year":"2003","journal-title":"Science"},{"key":"2023011710414760100_B5","doi-asserted-by":"crossref","first-page":"R335","DOI":"10.1186\/ar1192","article-title":"CD25brightCD4+ regulatory T cells are enriched in inflamed joints of patients with chronic rheumatic disease","volume":"6","author":"Cao","year":"2004","journal-title":"Arthritis Res. Ther."},{"key":"2023011710414760100_B6","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1002\/eji.201243296","article-title":"CD161 expression characterizes a subpopulation of human regulatory T cells that produces IL-17 in a STAT3-dependent manner","volume":"43","author":"Afzali","year":"2013","journal-title":"Eur. J. Immunol."},{"key":"2023011710414760100_B7","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/nrrheum.2014.105","article-title":"TREG-cell therapies for autoimmune rheumatic diseases","volume":"10","author":"Miyara","year":"2014","journal-title":"Nat. Rev. Rheumatol."},{"key":"2023011710414760100_B8","doi-asserted-by":"crossref","first-page":"6123","DOI":"10.4049\/jimmunol.178.10.6123","article-title":"Pertussis toxin by inducing IL-6 promotes the generation of IL-17-producing CD4 cells","volume":"178","author":"Chen","year":"2007","journal-title":"J. Immunol."},{"key":"2023011710414760100_B9","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1084\/jem.20061531","article-title":"Anti-TNF-\u03b1 therapy induces a distinct regulatory T cell population in patients with rheumatoid arthritis via TGF-\u03b2","volume":"204","author":"Nadkarni","year":"2007","journal-title":"J. Exp. Med."},{"key":"2023011710414760100_B10","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1089\/acm.2005.11.521","article-title":"Medicinal benefits of green tea, part I: review of noncancer health benefits","volume":"11","author":"Cooper","year":"2005","journal-title":"J. Altern. Complement. Med."},{"issue":"2:, Suppl","key":"2023011710414760100_B11","article-title":"Green tea in chemoprevention of cancer","volume":"52","author":"Mukhtar","year":"1999","journal-title":"Toxicol. Sci."},{"key":"2023011710414760100_B12","doi-asserted-by":"crossref","first-page":"4524","DOI":"10.1073\/pnas.96.8.4524","article-title":"Prevention of collagen-induced arthritis in mice by a polyphenolic fraction from green tea","volume":"96","author":"Haqqi","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"2023011710414760100_B13","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.taap.2013.09.021","article-title":"Green tea polyphenol, (-)-epigallocatechin-3-gallate, induces toxicity in human skin cancer cells by targeting \u03b2-catenin signaling","volume":"273","author":"Singh","year":"2013","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"2023011710414760100_B14","doi-asserted-by":"crossref","first-page":"364","DOI":"10.3109\/08923973.2014.953637","article-title":"Immunomodulatory effects of EGCG fraction of green tea extract in innate and adaptive immunity via T regulatory cells in murine model","volume":"36","author":"Kuo","year":"2014","journal-title":"Immunopharmacol. Immunotoxicol."},{"key":"2023011710414760100_B15","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1002\/art.24488","article-title":"Down-regulation of myeloid cell leukemia 1 by epigallocatechin-3-gallate sensitizes rheumatoid arthritis synovial fibroblasts to tumor necrosis factor \u03b1-induced apoptosis","volume":"60","author":"Ahmed","year":"2009","journal-title":"Arthritis Rheum."},{"key":"2023011710414760100_B16","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1006\/bbrc.2002.6622","article-title":"Fenton reaction is primarily involved in a mechanism of (-)-epigallocatechin-3-gallate to induce osteoclastic cell death","volume":"292","author":"Nakagawa","year":"2002","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"2023011710414760100_B17","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.3945\/jn.108.089912","article-title":"Green tea protects rats against autoimmune arthritis by modulating disease-related immune events","volume":"138","author":"Kim","year":"2008","journal-title":"J. Nutr."},{"key":"2023011710414760100_B18","doi-asserted-by":"crossref","first-page":"14692","DOI":"10.1073\/pnas.0802675105","article-title":"Epigallocatechin-3-gallate inhibits IL-6 synthesis and suppresses transsignaling by enhancing soluble gp130 production","volume":"105","author":"Ahmed","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"2023011710414760100_B19","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s00296-008-0597-5","article-title":"Epigallocatechin-3-gallate suppresses TNF-\u03b1\u2013induced production of MMP-1 and \u22123 in rheumatoid arthritis synovial fibroblasts","volume":"29","author":"Yun","year":"2008","journal-title":"Rheumatol. Int."},{"key":"2023011710414760100_B20","doi-asserted-by":"crossref","first-page":"5256","DOI":"10.4049\/jimmunol.1201675","article-title":"The novel role of IL-7 ligation to IL-7 receptor in myeloid cells of rheumatoid arthritis and collagen-induced arthritis","volume":"190","author":"Chen","year":"2013","journal-title":"J. Immunol."},{"key":"2023011710414760100_B21","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1038\/nm1284","article-title":"Blockade of PI3K\u03b3 suppresses joint inflammation and damage in mouse models of rheumatoid arthritis","volume":"11","author":"Camps","year":"2005","journal-title":"Nat. Med."},{"key":"2023011710414760100_B22","doi-asserted-by":"crossref","first-page":"4353","DOI":"10.1128\/JVI.03050-13","article-title":"Identification of a broad-spectrum antiviral small molecule against severe acute respiratory syndrome coronavirus and Ebola, Hendra, and Nipah viruses by using a novel high-throughput screening assay","volume":"88","author":"Elshabrawy","year":"2014","journal-title":"J. Virol."},{"key":"2023011710414760100_B23","doi-asserted-by":"crossref","first-page":"e50366","DOI":"10.1371\/journal.pone.0050366","article-title":"Human monoclonal antibodies against highly conserved HR1 and HR2 domains of the SARS-CoV spike protein are more broadly neutralizing","volume":"7","author":"Elshabrawy","year":"2012","journal-title":"PLoS One"},{"key":"2023011710414760100_B24","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.clim.2014.04.014","article-title":"A novel pancreatic \u03b2-cell targeting bispecific-antibody (BsAb) can prevent the development of type 1 diabetes in NOD mice","volume":"153","author":"Bhattacharya","year":"2014","journal-title":"Clin. Immunol."},{"key":"2023011710414760100_B25","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1124\/mol.109.057877","article-title":"Epigallocatechin-3-gallate inhibits osteoclastogenesis by down-regulating c-Fos expression and suppressing the nuclear factor-kPB signal","volume":"77","author":"Lee","year":"2010","journal-title":"Mol. Pharmacol."},{"key":"2023011710414760100_B26","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1136\/ard.62.10.983","article-title":"IFN\u03b3 deficient C57BL\/6 (H-2b) mice develop collagen induced arthritis with predominant usage of T cell receptor V\u03b26 and V\u03b28 in arthritic joints","volume":"62","author":"Chu","year":"2003","journal-title":"Ann. Rheum. Dis."},{"key":"2023011710414760100_B27","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1038\/35046102","article-title":"T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-gamma","volume":"408","author":"Takayanagi","year":"2000","journal-title":"Nature"},{"key":"2023011710414760100_B28","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.immuni.2007.11.016","article-title":"T helper 17 lineage differentiation is programmed by orphan nuclear receptors ROR\u03b1 and ROR\u03b3","volume":"28","author":"Yang","year":"2008","journal-title":"Immunity"},{"key":"2023011710414760100_B29","doi-asserted-by":"crossref","first-page":"4313","DOI":"10.4049\/jimmunol.179.7.4313","article-title":"Cutting edge: an in vivo requirement for STAT3 signaling in TH17 development and TH17-dependent autoimmunity","volume":"179","author":"Harris","year":"2007","journal-title":"J. Immunol."},{"key":"2023011710414760100_B30","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.imlet.2013.11.006","article-title":"Epigallocatechin-3-gallate ameliorates both obesity and autoinflammatory arthritis aggravated by obesity by altering the balance among CD4+ T-cell subsets","volume":"157","author":"Byun","year":"2014","journal-title":"Immunol. Lett."},{"key":"2023011710414760100_B31","doi-asserted-by":"crossref","first-page":"e86062","DOI":"10.1371\/journal.pone.0086062","article-title":"EGCG attenuates autoimmune arthritis by inhibition of STAT3 and HIF-1\u03b1 with Th17\/Treg control","volume":"9","author":"Yang","year":"2014","journal-title":"PLoS One"},{"key":"2023011710414760100_B32","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/j.fct.2007.10.006","article-title":"Modulation of Nrf2-mediated antioxidant and detoxifying enzyme induction by the green tea polyphenol EGCG","volume":"46","author":"Na","year":"2008","journal-title":"Food Chem. Toxicol."},{"key":"2023011710414760100_B33","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1186\/ar1447","article-title":"Oxidation in rheumatoid arthritis","volume":"6","author":"Hitchon","year":"2004","journal-title":"Arthritis Res. Ther."},{"key":"2023011710414760100_B34","doi-asserted-by":"crossref","first-page":"R189","DOI":"10.1186\/ar2102","article-title":"Reactive oxygen species induce expression of vascular endothelial growth factor in chondrocytes and human articular cartilage explants","volume":"8","author":"Fay","year":"2006","journal-title":"Arthritis Res. Ther."},{"key":"2023011710414760100_B35","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1089\/ars.2010.3835","article-title":"Deficiency of Nrf2 accelerates the effector phase of arthritis and aggravates joint disease","volume":"15","author":"Maicas","year":"2011","journal-title":"Antioxid. Redox Signal."},{"key":"2023011710414760100_B36","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.freeradbiomed.2011.05.016","article-title":"Epigallocatechin-3-gallate prevents lupus nephritis development in mice via enhancing the Nrf2 antioxidant pathway and inhibiting NLRP3 inflammasome activation","volume":"51","author":"Tsai","year":"2011","journal-title":"Free Radic. Biol. Med."},{"key":"2023011710414760100_B37","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.taap.2012.03.024","article-title":"EGCG protects endothelial cells against PCB 126-induced inflammation through inhibition of AhR and induction of Nrf2-regulated genes","volume":"261","author":"Han","year":"2012","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"2023011710414760100_B38","doi-asserted-by":"crossref","first-page":"e31067","DOI":"10.1371\/journal.pone.0031067","article-title":"EGCG enhances the therapeutic potential of gemcitabine and CP690550 by inhibiting STAT3 signaling pathway in human pancreatic cancer","volume":"7","author":"Tang","year":"2012","journal-title":"PLoS One"},{"key":"2023011710414760100_B39","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.3748\/wjg.v17.i18.2315","article-title":"(-)-Epigallocatechin-3-gallate inhibits VEGF expression induced by IL-6 via Stat3 in gastric cancer","volume":"17","author":"Zhu","year":"2011","journal-title":"World J. Gastroenterol."},{"key":"2023011710414760100_B40","doi-asserted-by":"crossref","first-page":"3543","DOI":"10.1002\/art.34601","article-title":"Modulation of STAT-3 in rheumatoid synovial T cells suppresses Th17 differentiation and increases the proportion of Treg cells","volume":"64","author":"Ju","year":"2012","journal-title":"Arthritis Rheum."},{"key":"2023011710414760100_B41","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.4049\/jimmunol.0901509","article-title":"Pharmacologic inhibition of MEK\u2013ERK signaling enhances Th17 differentiation","volume":"184","author":"Tan","year":"2010","journal-title":"J. Immunol."},{"key":"2023011710414760100_B42","doi-asserted-by":"crossref","first-page":"409","DOI":"10.4049\/jimmunol.161.1.409","article-title":"Enhancing effect of IL-17 on IL-1-induced IL-6 and leukemia inhibitory factor production by rheumatoid arthritis synoviocytes and its regulation by Th2 cytokines","volume":"161","author":"Chabaud","year":"1998","journal-title":"J. Immunol."},{"key":"2023011710414760100_B43","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1002\/1529-0131(200109)44:9<2176::AID-ART371>3.0.CO;2-4","article-title":"Interleukin-17 enhances tumor necrosis factor \u03b1-induced synthesis of interleukins 1, 6, and 8 in skin and synovial fibroblasts: a possible role as a \u201cfine-tuning cytokine\u201d in inflammation processes","volume":"44","author":"Katz","year":"2001","journal-title":"Arthritis Rheum."},{"key":"2023011710414760100_B44","doi-asserted-by":"crossref","first-page":"R29","DOI":"10.1186\/ar2936","article-title":"Interleukin-17A upregulates receptor activator of NF-kappaB on osteoclast precursors","volume":"12","author":"Adamopoulos","year":"2010","journal-title":"Arthritis Res. Ther."},{"key":"2023011710414760100_B45","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1136\/annrheumdis-2011-201024","article-title":"Incomplete response of inflammatory arthritis to TNF\u03b1 blockade is associated with the Th17 pathway","volume":"71","author":"Alzabin","year":"2012","journal-title":"Ann. Rheum. Dis."},{"key":"2023011710414760100_B46","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1002\/art.23594","article-title":"(-)-Epigallocatechin-3-gallate suppresses osteoclast differentiation and ameliorates experimental arthritis in mice","volume":"58","author":"Morinobu","year":"2008","journal-title":"Arthritis Rheum."},{"key":"2023011710414760100_B47","doi-asserted-by":"crossref","first-page":"3503","DOI":"10.4049\/jimmunol.163.6.3503","article-title":"Enhanced autoimmune arthritis in IFN-\u03b3 receptor-deficient mice is conditioned by mycobacteria in Freund\u2019s adjuvant and by increased expansion of Mac-1+ myeloid cells","volume":"163","author":"Matthys","year":"1999","journal-title":"J. Immunol."},{"key":"2023011710414760100_B48","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1007\/s10753-012-9457-2","article-title":"A novel combination of methotrexate and epigallocatechin attenuates the overexpression of pro-inflammatory cartilage cytokines and modulates antioxidant status in adjuvant arthritic rats","volume":"35","author":"Roy","year":"2012","journal-title":"Inflammation"}],"container-title":["Journal of Leukocyte Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1189%2Fjlb.3A0514-261RR","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jleukbio\/article-pdf\/100\/3\/559\/48716667\/jlb0559.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jleukbio\/article-pdf\/100\/3\/559\/48716667\/jlb0559.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,27]],"date-time":"2023-02-27T13:32:48Z","timestamp":1677504768000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jleukbio\/article\/100\/3\/559\/6932866"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,8]]},"references-count":48,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2016,3,8]]},"published-print":{"date-parts":[[2016,9,1]]}},"URL":"https:\/\/doi.org\/10.1189\/jlb.3a0514-261rr","relation":{},"ISSN":["0741-5400","1938-3673"],"issn-type":[{"value":"0741-5400","type":"print"},{"value":"1938-3673","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2016,9]]},"published":{"date-parts":[[2016,3,8]]}}}